Hey @tossydog......Dr Sud through cannavalate I believe have moved on to their next venture. He is the chief medical advisor at IRX leading their clinical trials looking at treating pain and anxiety through measured dose inhaled cannibinoid formulations. He is also the CEO of Ingenu conducting the trials. I think people of his calibre are always looking for their next project and IRX plus the one you outlined are currently it. Cannavalate are also IRX No.1 shareholder with nearly 20% of shares on issue. So I dont think anything is up with Sud its just that he has switched focus to his other projects!!!
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-16556
-
- There are more pages in this discussion • 3,429 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)